SCOPUS 정보 검색 플랫폼

Volumn 80, Issue 1, 2005, Pages 131-133

Weight gain and lipid metabolic abnormalities induced by olanzapine in first-episode, drug-naïve patients with psychotic disorders

(6) Sengupta, Sarojini M a Klink, Ruby a Stip, Emmanuel a Baptista, Trino a Malla, Ashok a Joober, Ridha a,b

a CENTRE DE RECHERCHE FERNAND SEGUIN (Canada)

b FBC 2 2142 ^* (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLANZAPINE; TRIACYLGLYCEROL;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LETTER; LIPID METABOLISM; MALE; METABOLIC DISORDER; PRIORITY JOURNAL; PSYCHOSIS; SIDE EFFECT; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ADULT; BENZODIAZEPINES; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERLIPIDEMIAS; MALE; PROSPECTIVE STUDIES; PSYCHOTIC DISORDERS; WEIGHT GAIN;

EID: 27744568397 PISSN: 09209964 EISSN: None Source Type: Journal
DOI: 10.1016/j.schres.2005.07.024 Document Type: Letter

Times cited : (23)

References (9)

1
- 0038070239
- Weight gain in first-episode psychosis
- J. Addington, C. Mansley, and D. Addington Weight gain in first-episode psychosis Can. J. Psychiatry 48 2003 272 275
- (2003) Can. J. Psychiatry , vol.48 , pp. 272-275
- Addington, J.¹ Mansley, C.² Addington, D.³

2
- 0032751075
- Antipsychotic-induced weight gain: A comprehensive research synthesis
- D.B. Allison, J.L. Mentore, M. Heo, L.P. Chandler, J.C. Cappelleri, M.C. Infante, and P.J. Weiden Antipsychotic-induced weight gain: a comprehensive research synthesis Am. J. Psychiatry 156 1999 1686 1696
- (1999) Am. J. Psychiatry , vol.156 , pp. 1686-1696
- Allison, D.B.¹ Mentore, J.L.² Heo, M.³ Chandler, L.P.⁴ Cappelleri, J.C.⁵ Infante, M.C.⁶ Weiden, P.J.⁷

3
- 2942741092
- Antipsychotic-induced weight gain and metabolic abnormalities: Implications for increased mortality in patients with schizophrenia
- D.E. Casey, D.W. Haupt, J.W. Newcomer, D.C. Henderson, M.J. Sernyak, M. Davidson, J. Lindenmayer, S.V. Manoukian, M.A. Banerji, H.E. Lebovitz, and C.H. Hennekens Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia J. Clin. Psychiatry 65 suppl 7 2004 4 18
- (2004) J. Clin. Psychiatry , vol.65 , Issue.7 SUPPL. , pp. 4-18
- Casey, D.E.¹ Haupt, D.W.² Newcomer, J.W.³ Henderson, D.C.⁴ Sernyak, M.J.⁵ Davidson, M.⁶ Lindenmayer, J.⁷ Manoukian, S.V.⁸ Banerji, M.A.⁹ Lebovitz, H.E.¹⁰ Hennekens, C.H.¹¹

4
- 0345575653
- Outpatient prescriptions for atypical antipsychotics for African Americans, Hispanics, and Whites in the United States
- G.L. Daumit, R.M. Crum, E. Guallar, N.R. Powe, A.B. Primm, D.M. Steinwachs, and D.E. Ford Outpatient prescriptions for atypical antipsychotics for African Americans, Hispanics, and Whites in the United States Arch. Gen. Psychiatry 60 2003 121 128
- (2003) Arch. Gen. Psychiatry , vol.60 , pp. 121-128
- Daumit, G.L.¹ Crum, R.M.² Guallar, E.³ Powe, N.R.⁴ Primm, A.B.⁵ Steinwachs, D.M.⁶ Ford, D.E.⁷

5
- 11844303449
- Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis
- K.A. Graham, D.O. Perkins, L.J. Edwards, R.C. Barrier, J.A. Lieberman, and J.B. Harp Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis Am. J. Psychiatry 162 2005 118 123
- (2005) Am. J. Psychiatry , vol.162 , pp. 118-123
- Graham, K.A.¹ Perkins, D.O.² Edwards, L.J.³ Barrier, R.C.⁴ Lieberman, J.A.⁵ Harp, J.B.⁶

6
- 0042882529
- Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: A randomized, double-blind trial of Olanzapine versus Haloperidol
- (HGDH study group) R.M.
- J.A. Lieberman, G. Tollefson, M. Tohen, A.I. Green, R.E. Gur, R. Kahn, J. McEvoy, D. Perkins, T. Sharma, R. Zipursky, H. Wei, R.M. Hammer (HGDH study group) Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of Olanzapine versus Haloperidol Am. J. Psychiatry 160 2003 1396 1404
- (2003) Am. J. Psychiatry , vol.160 , pp. 1396-1404
- Lieberman, J.A.¹ Tollefson, G.² Tohen, M.³ Green, A.I.⁴ Gur, R.E.⁵ Kahn, R.⁶ McEvoy, J.⁷ Perkins, D.⁸ Sharma, T.⁹ Zipursky, R.¹⁰ Wei, H.¹¹ Hammer¹²

7
- 13544253065
- Metabolic syndrome: A clinical and molecular perspective
- D.E. Moller, and K.D. Kaufman Metabolic syndrome: a clinical and molecular perspective Annu. Rev. Med. 56 2005 45 62
- (2005) Annu. Rev. Med. , vol.56 , pp. 45-62
- Moller, D.E.¹ Kaufman, K.D.²

8
- 0037214218
- A review of the effect of atypical antipsychotics on weight
- H. Nasrallah A review of the effect of atypical antipsychotics on weight PNEC 28 2003 83 96
- (2003) PNEC , vol.28 , pp. 83-96
- Nasrallah, H.¹

9
- 0030791781
- Dosing the antipsychotic medication olanzapine
- C.B. Nemeroff Dosing the antipsychotic medication olanzapine J. Clin. Psychiatry 58 suppl 10 1997 45 49
- (1997) J. Clin. Psychiatry , vol.58 , Issue.10 SUPPL. , pp. 45-49
- Nemeroff, C.B.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.